Ortho-Clinical Diagnostics
QuidelOrtho (operating as Ortho-Clinical Diagnostics, Nasdaq: OCDX) is an in vitro diagnostics company offering 550+ assays across clinical chemistry, immunoassay, immunohematology, molecular diagnostics, and point-of-care testing, serving hospital laboratories, reference labs, blood banks, healthcare providers, and consumers in 140+ countries.
- Company typePublic
- Founded2022
- HeadquartersRaritan, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ortho-Clinical Diagnostics does
Ortho-Clinical Diagnostics operates as QuidelOrtho Corporation (Nasdaq: OCDX), an in vitro diagnostics company formed by the May 2022 merger of Quidel Corporation and Ortho Clinical Diagnostics (originally part of Johnson & Johnson, founded 1939). The company is headquartered in San Diego, California, with 1,001–5,000 employees, and serves laboratory professionals, healthcare providers, and consumers across 140+ countries and territories. Its core technology spans clinical chemistry and immunoassay systems (VITROS, SOFIA), immunohematology/blood bank analyzers (ORTHO VISION Swift, ORTHO Workstation, ORTHO OPTIX Reader, ORTHO Summit), molecular diagnostic platforms (LYRA real-time PCR assays, SOLANA, SAVANNA, VIRENA), and point-of-care rapid tests (QUICKVUE, TRIAGE). Supporting offerings include ORTHO CONNECT lab management software, QuidelOrthoCQ quality control, and VALUMETRIX lab consulting services, with a portfolio of more than 550 assays.
The company operates a dual revenue model: hardware/equipment sales of diagnostic instrument systems and point-of-care devices, paired with high-margin recurring revenue from proprietary assays, reagents, and consumables consumed on its installed base. It goes to market primarily through an enterprise field sales organization targeting hospital laboratories, reference laboratories, blood banks, and healthcare providers, complemented by the Ortho Plus customer portal for ordering and support and a retail/consumer channel for at-home QUICKVUE COVID-19 tests. Strategic initiatives include the 2026 acquisition of Lex Diagnostics (adding the Nulexa System), the Allo Hope Foundation partnership for alloimmunized pregnancy testing, and ongoing geographic localization across Europe, MEA, APAC, and the Americas.
Ortho-Clinical Diagnostics firmographics
Firmographics- Name
- Ortho-Clinical Diagnostics
- Legal name
- QuidelOrtho Corporation
- Website
- https://orthoclinical.com
- Company type
- Public
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- QuidelOrtho (operating as Ortho-Clinical Diagnostics, Nasdaq: OCDX) is an in vitro diagnostics company offering 550+ assays across clinical chemistry, immunoassay, immunohematology, molecular diagnostics, and point-of-care testing, serving hospital laboratories, reference labs, blood banks, healthcare providers, and consumers in 140+ countries.
- Ownership category
- akta.pro rank
Ortho-Clinical Diagnostics industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Systems (HLAHAAAA)
- akta.pro secondary industries
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)
Keywords
Where Ortho-Clinical Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Raritan
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ortho-Clinical Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Instruments and Systems: Sale of diagnostic instrument systems including VITROS systems, SOFIA analyzers, ORTHO VISION systems, and related equipment
- Assays and Reagents: Recurring revenue from sale of assay tests and reagents consumables used on their instrument platforms across clinical chemistry, immunoassay, immunohematology and molecular diagnostics
- Point-of-Care Testing Products: Sale of rapid diagnostic tests including QUICKVUE lateral-flow tests for consumer and professional use
- Immunohematology Solutions: Blood bank testing solutions including ORTHO Workstation, ORTHO OPTIX Reader for transfusion medicine
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Ortho-Clinical Diagnostics product offering
Product offeringCore offering
Ortho-Clinical Diagnostics (QuidelOrtho) manufactures and sells in vitro diagnostic instruments, reagents and assays used by hospital laboratories, reference labs, blood banks, clinics and pharmacies to perform clinical chemistry, immunoassay, immunohematology, molecular, and point-of-care diagnostic testing. Its offering combines proprietary analyzer platforms (VITROS, SOFIA, ORTHO VISION Swift, ORTHO Workstation/Summit, SAVANNA, SOLANA, TRIAGE) with a recurring consumable menu of more than 550 assays, plus rapid lateral-flow tests such as QUICKVUE and an at-home COVID-19 antigen test sold through retail.
Product overview
QuidelOrtho (operating as Ortho Clinical Diagnostics, Nasdaq: OCDX) offers a comprehensive in vitro diagnostics portfolio spanning clinical chemistry, immunoassay, molecular diagnostics, immunohematology, and point-of-care testing. The core platform consists of VITROS Systems for automated chemistry and immunoassay testing, supported by the SOFIA Platform for rapid benchtop diagnostics, ORTHO VISION Swift and ORTHO Workstation for immunohematology/blood bank testing, and molecular platforms including SAVANNA, SOLANA, and LYRA assays for real-time PCR. The portfolio includes over 550 assays offered across 140+ countries, featuring products like QUICKVUE rapid tests (including COVID-19), TRIAGE point-of-care systems, and specialized tests for thyroid function, bone health, and autoimmune conditions. The company also provides supporting solutions including ORTHO CONNECT lab management software, VITROS Automation Solutions for workflow integration, and quality control products like QuidelOrthoCQ and VALUMETRIX consulting services.
Differentiator
Problem solved
Functional benefit
Brands
- VITROS: VITROS Systems for clinical chemistry and immunoassay testing
- QUICKVUE
- SOFIA
- ORTHO VISION
- ORTHO OPTIX
- LYRA
- TRIAGE
- SAVANNA
- SOLANA
- VIRENA
- MICROVUE
- ORTHO CONNECT
- QuidelOrthoCQ
- VALUMETRIX
- ELVIS
- D3
Products and services
- VITROS Systems Automated clinical chemistry and immunoassay analyzer systems that deliver fast, accurate, and reliable diagnostic results for hospital, reference and clinical laboratories of every size.
- SOFIA Platform Benchtop diagnostic testing platform, including the SOFIA 2 Analyzer, designed for rapid immunoassay testing at the point of care for healthcare providers.
- ORTHO VISION Swift Automated Immunohematology System Automated blood-bank analyzer providing enhanced processing power, responsiveness and data security for high-volume immunohematology testing in transfusion medicine labs.
- ORTHO OPTIX Reader Semi-automated blood-bank analyzer that integrates with the ORTHO Workstation to deliver complete immunohematology testing solutions for transfusion laboratories.
- ORTHO Workstation Immunohematology Analyzer Scalable semi-automated immunohematology solution built around proven column agglutination technology for transfusion laboratories.
- ORTHO Summit System High-throughput automated immunohematology system designed for large-scale blood-bank operations.
- LYRA Assays Real-time PCR assays for molecular testing, designed as an open-platform solution for high-quality molecular diagnostics in laboratories.
- QUICKVUE Rapid Lateral-Flow Tests Rapid lateral-flow diagnostic tests that produce accurate results in minutes, supporting faster diagnoses and improved patient outcomes in point-of-care settings.
- QUICKVUE COVID-19 Test At-home rapid COVID-19 antigen test designed for fast, simple, and easy use by individual consumers and available through retail channels.
- TRIAGE System Point-of-care diagnostic system providing rapid, lab-quality immunoassay results for various clinical conditions in healthcare provider settings.
- SOLANA Molecular Testing Platform Molecular diagnostic testing platform for syndromic infectious disease testing at the point of care.
- SAVANNA Platform Multi-assay molecular diagnostic platform for rapid infectious disease detection.
- VIRENA System Molecular diagnostic system for infectious disease testing and surveillance.
- ORTHO CONNECT Lab Management Software Laboratory management software solution for data integration and workflow optimization across the company's diagnostic instrument portfolio.
- MICROVUE Products Immunoassay products for diagnostic applications including autoimmune testing and complement protein measurement.
- THYRETAIN Thyroid BioAssays Thyroid function diagnostic bioassays for clinical use.
- INFLAMMADRY MMP-9 Test Point-of-care test for detecting Matrix Metalloproteinase-9, used in inflammatory condition assessment.
- D3 Products - Virus Testing Solutions Virus testing solutions for diagnostic applications.
- ELVIS HSV Test System Herpes simplex virus diagnostic test system using direct fluorescent antibody technology.
- CUSTOMCELLS Custom cell products for diagnostic and research applications.
- READYCELLS Rapid Culture System Rapid cell culture system for accelerated diagnostic results.
- VALUMETRIX Lab Consulting Services Laboratory consulting services that help customers optimize diagnostic lab operations, workflow and efficiency.
- QuidelOrthoCQ Quality control products and program for diagnostic testing across the QuidelOrtho portfolio.
- Nulexa System Diagnostic system acquired from Lex Diagnostics in 2026 that expands QuidelOrtho's in vitro diagnostics product portfolio.
Companies that use Ortho-Clinical Diagnostics
Customer profileSegments3 records
Ideal customer profiles2 records
Ortho-Clinical Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Ortho-Clinical Diagnostics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Allo Hope FoundationcoreQuidelOrtho and Allo Hope Foundation joined forces to advance education, connection, and early testing for alloimmunized pregnancies. The partnership focuses on improving awareness and testing for blood compatibility issues during pregnancy to prevent complications from alloimmunization.
- Allo Hope FoundationcoreCollaboration to improve education and early testing awareness for alloimmunized pregnancies, demonstrating commitment to women's health and pregnancy care diagnostics.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Ortho-Clinical Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Global IVD leader with cobas clinical chemistry/immunoassay, blood screening, and molecular platforms that compete head-on with VITROS across hospital and reference lab channels.
- Abbott Diagnostics: Operates ARCHITECT clinical chemistry/immunoassay, Alinity, and rapid point-of-care diagnostics, providing overlapping menu and global reach comparable to QuidelOrtho.
- Siemens Healthineers: Atellica and ADVIA Centaur chemistry/immunoassay systems plus an immunohematology and molecular portfolio that directly competes with VITROS and ORTHO VISION in hospital core labs.
- Beckman Coulter Diagnostics (Danaher): DxH/AU clinical chemistry, Access immunoassay, and DxI automation compete directly with VITROS for high-throughput lab share and against QuidelOrtho's automation solutions.
- Thermo Fisher Scientific (Diagnostics): Operates a broad IVD and specialty diagnostics portfolio including immunoassays and clinical chemistry reagents, overlapping with multiple QuidelOrtho product lines globally.
Direct peers
- bioMérieux: VITEK and VIDAS clinical chemistry/immunoassay plus industrial microbiology overlap with QuidelOrtho's clinical diagnostic and infectious disease testing franchises.
- Hologic: Panther molecular diagnostics platform and Aptima assays overlap directly with QuidelOrtho's SOLANA, SAVANNA, and LYRA molecular test menus in hospital labs.
- Becton Dickinson (BD): BD MAX and BD Veritor molecular/rapid diagnostics plus MaxCollection lab supplies overlap with QuidelOrtho's molecular and point-of-care offerings.
- Bio-Rad Laboratories: Provides clinical chemistry, immunoassay, and quality controls (Unity) that closely parallel VITROS QC Solutions and QuidelOrthoCQ offerings for hospital and reference labs.
- Sysmex: Leading hematology and hemostasis vendor with growing clinical chemistry ambitions; competes with QuidelOrtho in blood bank/immunohematology workflow instruments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Ortho-Clinical Diagnostics social profiles
Digital presenceOrtho-Clinical Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ortho-Clinical Diagnostics leadership team
Management profileNumber of profiles
Profiles4 records
Ortho-Clinical Diagnostics subsidiaries and ownership
Company hierarchySubsidiaries1 record
Ortho-Clinical Diagnostics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ortho-Clinical Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ortho-Clinical Diagnostics
What does Ortho-Clinical Diagnostics do?
Ortho-Clinical Diagnostics (QuidelOrtho) manufactures and sells in vitro diagnostic instruments, reagents and assays used by hospital laboratories, reference labs, blood banks, clinics and pharmacies to perform clinical chemistry, immunoassay, immunohematology, molecular, and point-of-care diagnostic testing. Its offering combines proprietary analyzer platforms (VITROS, SOFIA, ORTHO VISION Swift, ORTHO Workstation/Summit, SAVANNA, SOLANA, TRIAGE) with a recurring consumable menu of more than 550 assays, plus rapid lateral-flow tests such as QUICKVUE and an at-home COVID-19 antigen test sold through retail.
Is Ortho-Clinical Diagnostics a public or private company?
Ortho-Clinical Diagnostics is a public company. It is classified as public and is currently operating.
When was Ortho-Clinical Diagnostics founded?
Ortho-Clinical Diagnostics was founded in 2022. It employs 1,001 to 5,000 people.
Where is Ortho-Clinical Diagnostics based?
Ortho-Clinical Diagnostics is headquartered in Raritan, United States, in the North America region.
How does Ortho-Clinical Diagnostics make money?
Four revenue lines are on record. Diagnostic Instruments and Systems are the primary driver. The others are assays and Reagents, point-of-Care Testing Products and immunohematology Solutions.
Who are Ortho-Clinical Diagnostics's main competitors?
Broad incumbents on record are Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Beckman Coulter Diagnostics (Danaher) and Thermo Fisher Scientific (Diagnostics). Direct peers are bioMérieux, Hologic, Becton Dickinson (BD), Bio-Rad Laboratories and Sysmex.
Does Ortho-Clinical Diagnostics have an API?
No public API is recorded for Ortho-Clinical Diagnostics.
What industry is Ortho-Clinical Diagnostics in?
Ortho-Clinical Diagnostics's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAA, Clinical Chemistry & Immunoassay Systems, with a secondary code of HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.